Sotera Health Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sotera Health Company generated cash of -$147,732,000, which is less than the previous year. Cash used in financing activities reached the amount of $265,959,000 last year. Net change in cash is therefore -$94,640,000.
Cash Flow
| 2018 | 119.56M | 96.63M | -191.85M |
|---|---|---|---|
| 2019 | 149.04M | -57.25M | -126.03M |
| 2020 | 120.58M | -158.69M | 73.43M |
| 2021 | 281.54M | -159.83M | -117.28M |
| 2022 | 277.96M | -181.89M | 197.76M |
| 2023 | -147.73M | -214.90M | 265.95M |
SHC Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 396.29M | 106.92M | 102.45M | 63.02M | 96.78M | 76.11M |
Operating activities | ||||||
Net income | 51.37M | -233.57M | 117.12M | -37.49M | -20.42M | -5.87M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 160.33M | 145.55M | 150.90M | 143.56M | 146.71M | 146.81M |
Stock-based compensation expense | 32.23M | 21.21M | 13.87M | 10.98M | 6.88M | 6.94M |
| Deferred income tax benefit | 32.23M | 21.21M | 13.87M | 10.98M | 6.88M | 6.94M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -21.72M | -12.55M | -15.50M | 1.94M | 11.76M | -2.90M |
Inventories | -9.97M | 14.44M | -20.24M | 3.78M | -282K | -7.04M |
Accounts payable | -5.33M | 1.10M | 19.76M | -6.02M | -8.96M | 15.12M |
Cash generated by operating activities | -147.73M | 277.96M | 281.54M | 120.58M | 149.04M | 119.56M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -214.97M | -182.37M | -102.16M | -53.50M | -57.25M | -72.61M |
Acquisitions Net | 0 | 450K | -56.97M | -105.18M | 0 | 162.82M |
Cash generated by investing activities | -214.90M | -181.89M | -159.83M | -158.69M | -57.25M | 96.63M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 1.15B | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -691.17M | -175.84M |
Repurchases of common stock | -4.08M | -393K | -1.43M | -34M | 0 | 0 |
Repayments of term debt | 297.5M | 200M | -100M | -1.17B | 583.51M | -14.63M |
Cash used in financing activities | 265.95M | 197.76M | -117.28M | 73.43M | -126.03M | -191.85M |
Net Change In Cash | -94.64M | 289.37M | 4.47M | 39.42M | -33.76M | 20.66M |
Cash at end of period | 301.65M | 396.29M | 106.92M | 102.45M | 63.02M | 96.78M |
| Data source | Data source | Data source | Data source |